The immortalized NK-92 cell line is widely used to study natural killer (NK) cell biology and develop immunotherapies. NK-92 cells exhibit strong cytotoxic activity against tumor and virus-infected ...

Finding out you’re sick is hard enough. Finding out you have a disease shared by less than 1% of the population with no established treatment is something else entirely. Rare disease breaks the ...

Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s most advanced immuno-oncology asset, the prostate cancer candidate VIR-5500, through a collaboration that could ...

There are hundreds of biotechnology companies today that have never commercialized a drug. For many years, the standard approach in the industry has been to advance the science, prove the asset, and ...

Krystal Biotech pioneered the first topical gene therapy. ARS Pharmaceuticals introduced the first needle-free therapy to treat anaphylaxis. Both therapies have blockbuster potential. 10 stocks we ...

As biotech and other sectors of the life sciences industry espouse cautious optimism for a stabler financing environment in 2026, a steady influx of new funds in the space suggests things are trending ...